View abstract

Cet abstract a été assigné à sessions

Type de présentation	E-poster
Titre	Overall Visual Outcomes from a Real-World Study of Presbyopia-Correcting IOLs in a Large Population

But	To present real-world visual and patient-reported outcomes in a large cohort of patients bilaterally implanted with the AcrySof IQ Vivity presbyopia-correcting IOL
Méthodes	Multicenter, ambispective registry study conducted in Europe, Australia and New Zealand. This cohort includes 4% post-corneal refractive surgery subjects and 28% with associated ocular comorbidities. At 3-6 months post-op, subjects bilaterally implanted underwent visual performance assessments. Patient satisfaction and spectacle independence were assessed with validated questionnaires. Patient reports of visual disturbance were also assessed
Résultats	910 subjects were available for analysis. The mean age was 67.1 ± 9.3 years. Binocular mean UCDVA was 0.01 ± 0.10 logMAR, UCIVA was 0.08 ± 0.12 logMAR, and UCNVA was 0.25 ± 0.15 logMAR. Mean MRSE (first eye) was -0.19 ± 0.39 D (23.7% had mini-monovision). Most subjects (91.4%) reported being satisfied with their vision. The percentage of subjects reporting never/rarely needing to wear glasses to see up close was 60.2%, at arm’s length 89.2%, and far away 93.4%. The percentage of subjects reporting “none” for seeing halos was 91.5%, for glare 91.6%, and for starbursts 94.6%
Conclusion	In this real-world study in a diverse large population of subjects bilaterally implanted with the AcrySof IQ Vivity IOL, we have demonstrated excellent distance (20/20), intermediate (~20/25), and functional near (~20/32) visual acuity. In general, subjects reported high visual satisfaction with little or no difficulty in performing daily activities and very little visual disturbances.
Conflit d'intérêt	Oui
Détails conflits d'intérêt	Principal investigator in the Alcon Study

Auteur 1

Nom	CRAHAY
Initiales	F
Institut	hopital de la citadelle
Ville	liège